Industry / Russia
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Generics Still Dominate In The East
November 2007 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Although the drug markets in Russia and Ukraine grew rapidly in 2006-2007 both countries remain predominately generics-based. Low-cost copies account for 53% and 76% of the total market in Russia and Ukraine respectively. Yet, BMI believes that the market share for patented drugs will grow over the coming years due to a rise in the strength of the commercial sector coupled with liberal pricing